Showing results (41-50 of 738) with videos related to
Sort By:
Pageof 74
Immunity|December 14, 2022
The pathogenesis of rheumatoid arthritisStefano Alivernini, Gary S Firestein, Iain B McInnesThe Medical Clinics of North America|February 16, 2021
Managing Cardiovascular Risk in Patients with Rheumatic DiseaseLyn D Ferguson, Naveed Sattar, Iain B McInnesNature Reviews. Rheumatology|February 20, 2013
Back to the future: oral targeted therapy for RA and other autoimmune diseasesJohn J O'Shea, Arian Laurence, Iain B McInnesNature Reviews. Rheumatology|March 2, 2026
Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritisLilla Gunkl-Tóth, Iain B McInnes, György NagyJournal of the American Academy of Dermatology|July 5, 2021
Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasisJames G Krueger, Iain B McInnes, Andrew BlauveltImmunology and Cell Biology|January 18, 2012
Novel regulatory mechanisms in inflammatory arthritis: a role for microRNADerek Baxter, Iain B McInnes, Mariola Kurowska-StolarskaRheumatology (Oxford, England)|February 27, 2019
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritisGeorge E Fragoulis, Iain B McInnes, Stefan SiebertRheumatic Diseases Clinics of North America|April 11, 2022
Managing Cardiovascular Risk in Patients with Rheumatic DiseaseLyn D Ferguson, Naveed Sattar, Iain B McInnesArthritis & Rheumatology (Hoboken, N.J.)|September 9, 2025
Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritisAurelie Najm, Lyn D Ferguson, Iain B McInnesArthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyLaura C Coates, Iain B McInnes, Joseph F Merola, et al.Pageof 74